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ABSTRACT 
Aflatoxins B1, B2, G1 and G2, highly toxic mycological metabolic products occurring as 
food contaminants, were capable in minute quantities of causing delayed hyper-
sensitivity in guinea pigs. Structurally related compounds, sterigmatocystin (a 
mycotoxin), coumarin, 8-methoxypsoralen and furazolium chloride were also equally or 
more active in causing delayed hypersensitivity in guinea pigs. Animals which were 
strongly sensitized to aflatoxin B1 showed cross-reactivity to other aflatoxins (B2, G1 and 
G2), sterigmatocystin, coumarins, 8-methoxypsoralen, furans and commerical perfumes. 
Less strongly immunized animals, on the other hand, showed differential cross-reactivity 
in that other aflatoxins produced frank erythema whereas closely related compounds 
were more moderate in action. None of these immunized animals showed any circulating 
antibodies. 
Aflatoxins are metabolites of the fungus Asper-
gillus fiavus. These mycotoxins are highly toxic 
toward many species of animals including birds 
and humans (1). Aflatoxin B1, the most toxic 
of the aflatoxins, is a potent carcinogen for rats 
(2-4) and trout (5) , and is teratogenic in ham-
sters (6, 7). It combines with DNA in vitro (8, 
9) and probably in vivo (9, 10). It inhibits bio-
synthesis of DNA (11, 12), DNA-dependent 
RNA and proteins (9, 10, 12-14). In addition, 
it inhibits synthesis of chlorophyll (15) and in-
terferes with the function of messenger RNA in 
protein synthesis of cottonseeds (16). 
Aflatoxins contain an angelicin (or furo-
coumarin) moiety in their chemical structures (1, 
17, 18). Some of their biological functions are 
similar to other natural and synthetic coumarins 
and furocoumarins (1, 15-22). However, the only 
report of aflatoxins or other coumarins causing 
skin sensitization of delayed immune reaction or 
photoallergy in animals or humans is that of 
Fulton and Willis who studied 8-methoxypsora-
len in man (23) . The wide-spread presence and 
use of many furans, coumarins and furocoumar-
ins, and the possible presence of mycotoxins in 
small quantities in our daily food warrant a 
detailed study on their immunogenicity and 
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immunological cross-reactivity for safety of 
humans and other animals. 
This paper reports that aflatoxins, coumarin, 
nitrofuran and 8-methoxypsoralen are potent 
skin sensitizing allergens in guinea pigs. The 
aflatoxin B1-sensitized animals showed strong 
cross-reactivity to other mycotoxins, coumarins, 
furans, furocoumarins and some commercial 
perfumes. 
MATERIALS AND METHODS 
Animals. Male guinea pigs of Hartley albino 
strain weighing 300-400 grams were procured from 
Zar tman Farm, Douglasville, Pennsylvania. 
Chemicals. Aflatoxins were purchased from Cal-
biochem. Aflatoxin B analog I (a synthetic cou-
marin) and sterigmatocystin were prepared by 
Dr. J. Rodricks of the Food and Drug Administra-
tion. 
Furacin and furazolium were supplied by the 
Norwich Pharmacal Company, Norwich, New 
York. Other chemicals were obtained from K & K 
Laboratories, Inc .. Plainview, New York. 
Freund's complete adjuvant of Mycobacterium 
butyricum or M. tuberculosis, H37Ra, was diluted 
with Freund's incomplete adjuvant to desired 
strength of the mycobacterial material. All adju-
vants were products of Difco Laboratories, De-
troit, MichigRn. 
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All chemicals were dissolved in acetone or eth-
anol and, for injection, were then diluted in saline 
to the desired concentrations so that less than 5% 
of the solvent was present. If the final dilution was 
turbid, the preparation was well suspended before 
intradermal injection. At less than 5%, neither 
solvent in saline was toxic to intact guinea pig 
skin. 
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Induction of sensitization. Aflatoxins were dis-
solved in absolute ethanol or in acetone usually at 
a concentration of 2000 ,ug/ml and diluted in saline 
to concentrations of 20 ,ug/ml, 10 ,ug/ml and 1 
,u.g/ml. A total volume of 0.5 ml per animal .was 
introduced by the intradermal (I.D.) route n:~to 
five sites in the nuchal region as done by Magmre 
and Chase (24). Six guinea pigs were used for 
each concentration. Controls received 1.0, 0.5 or 
0.05% ethanol or acetone in saline in place of the 
aflatoxin solutions. The animals receiving adjuvant 
were given 0.1 ml of Freund's complete adjuvant 
in each of the four foot-pads for a total of 100 ,ug. 
Low concentrations of aflatoxin B1 were tried ini-
tially because of the fear that a highly toxic sub-
stance such as aflatoxin B1 might act as a strong 
immunosuppressant. 
Challenge. In regular delayed hypersensiti_vity 
experiments six to eight I.D. injections v:ere gr':"en 
into the close-clipped flanks of the gumea pigs, 
using four concentrations of the allergen rang~ng 
from 0.1 to 20 ,ug, in a volume of 0.1 ml per Site. 
An equal number of sites were prepared on each 
flank. Most of the mycotoxins and related com-
pounds were tested for cross-reactivity with. 2 
,u.g per 0.1 ml per site. but some were tested With 
multiple concentrations ranging from 0.1 to 5.0 
1-'g per site. 
Rating of contact sensitization . Three different 
systems were employed to rate the intensity of 
the skin reaction. 
Fractional response ( F R) rating. A rating sys-
tem for erythema similar to the method of Chase 
(25) was adopted '' ith modification of the max-
imum score of ++++, and tr for tr and f.tr. The 
skin erythema reaction (or redness) was evaluated 
under constant ligh ting and rated as o, tr, -+-, +, 
++ +++ or ++++ according to the degree of red~e s or erythema. Diameter, edema, necrosis 
and induration of the region were not considered. 
In the final judgment ratings, o, tr and -+- were 
taken as negat ive and the rest of the ratings, +, 
++ +++ and ++++, were considered positive. Th~ ratio of the number of the positive animals 
to the total number of guinea pigs is shown as a 
fraction of positive responses in Tables I-V. This 
conventional fract ional expression is an "all-or-
none" rating system. It does not transfer informa-
tion on the intensity of the reaction. 
Average intensity (AI) rating. In order to obvi-
ate some of the defects of the fractional rating 
system, numerical values were assigned to each 
rating: 0. 1. 2. 3. 4. 5 and 6 too, tr, ±, +. ++, +++ 
or ++++. respectively. The sum of all scores 
was divided by the total number of site for each 
concentration or animal to give the average in-
tensit~' per ite for each concentration or each 
animal. When different concentrations or amounts 
were applied to a single animal. the highest rat-
ing was reported, independent of concentrations 
or quantities applied or location of the test sites. 
In most cases higher concentrations gave stronger 
reactions. Often. however. lower concentrations 
gave stronger reactions and indeed, a weak reac-
1. AFLATOXIN 81 
0 
2. AFLATOXIN Bz 
3. AFLATOXIN G1 
4. AFLATOXIN Gz 
5. STERIGMATOCYSTIN 
FIG. 1. M ycotoxins 
tion or no reaction was sometimes observed with 
higher concentrations. Accordingly, it was neces-
sary to use several concentrations at first chal-
lenge. 
With this rating system, which is useful in de-
termining immunogenicity of a sensitizer (or an 
immunogen) under various conditions, a distinct 
difference from control values signifies delayed hy-
persensitivity or contact sensitization. An impor-
tant limitation of a one-dimensional rating system 
such as this is that it deals only with the average 
intensity of erythema and does not convey other 
inform~tion on the reaction. 
Average of area times average intensity (AAT I) 
of positive responses . The simplest erythema with-
out macroscopic edema, vesicles, induration or 
necrosis has at least two recognizable parameters: 
intensity and area. In positive reactions an approx-
imate area can be estimated from its two diame-
ters the lon(J' and short axes (one perpendicular 
' t> 
to the other) in an ellipsoidal erythematous reac-
' . tion. The product of area and the average mten-
sity of positive responses (AATI) expresses the 
results in a three..<fimensional rating. Variability 
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TABLE I 
Effect of induction dose on sensitization of guinea pigs to aflatoxin Bt 
All guinea pigs received 100 J.l.g of FCA (M. butyricum) in foot pads and three equal I.D. injections of 
aflatoxin B 1 every third day. 
Total aflatoxin B 1 used for induction {J.lg) 
Challenging dose of aflatoxin None 7.5 15 .0 30.0 B 1 per site {J.lg) 
FR AI AATI FR AI AATI FR AI AATI FR AI AATI 
--
-- -- ---- --
0.10 0/6 1.17 - 1/6 1.83 60 0/6 1.00 - 0/ 6 1.17 -
0.25 0/6 1.33 - 2/6 2.34 148 0/6 1.50 - 0/6 1.33 -
0.50 0/6 1.67 - 3/6 2.67 232 1/6 2.00 151 1/6 2.00 84 
1.00 0/6 1.67 - 6/6 3.67 291 3/6 2.66 335 3/ 6 2.34 204 
TABLE II 
Effect of adjuvant and repeated challenges on aflatoxin B1-sensitization 
Induction phase No. of challenges 
Experimental Time after 1 2 7 animal group Number Total dose of Adjuvant challenge of aflatoxin B 1 (M. I injections butyricum) FR AI FR AI FR AI 
J.'g J.'g lzrs. 
I 0 0 0 24 7/ 12 2.60 
48 0/ 12 0.33 
72 0/ 12 0.00 
II 1 4.7 0 24 6/6 3.33 
III 0 0 100 24 0/6 1.67 
IV* 1* 4.7* 0* 24 4/6 2.83 5/6 2.67 4/5 2.50 
48 3/6 2.17 5/ 5 2.67 
72 2/ 5 1.60 
v 3 7.5 100 24 6/6 3.67 6/6 3.17 5/ 5 3.20 
48 1/6 1.50 5/5 3.60 
72 1/5 1.60 
VI 3 15.0 100 24 3/6 2 .66 6/6 3.17 5/5 3.20 
48 1/6 1.17 5/ 5 3.60 
72 2/ 5 2.20 
VII 3 30.0 100 24 3/6 2.34 6/6 3.17 5/ 5 3.00 
48 0/6 1.33 5/5 3.20 
72 3/ 5 2.60 
* The initial adjuvant controls, group III , after the first challenge. Since the time elapsed after the 
first injection was far beyond the effective period of the adjuvant (23), the animals in this group (IV) 
were considered immunized without adjuvant. 
in the end result arises from a lack of uniformity 
of skin sites in the same or different animals, as 
well as from technical difficulties in inj ection such 
as an occasional partial leakage of injected mate-
rials. This rating system gives values by which 
to compare one positive reaction to another under 
different experimental conditions. Other values 
(FR and AI) may or may not show correspond-
ingly significant differences between previously 
treated and untreated control sites or animals. 
RESULTS 
ince aflatoxin B1 (Fig. 1, 1) has been re-
ported to be highly toxic (1 , 26-28) and there-
fore might act as a potent immunosuppressant 
(29), low concentrations were used for inducing 
delayed hypersensitivity. The initial I.D. admin-
istration of three different concentrations (2.5, 
5 and 10 ,u.g) of aflatoxin B1 was followed by 
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TABLE III 
Sensitization of guinea pigs to aflatoxin and related compounds 
All guinea pigs received Freund's adjuvant containing M. tuberculosis, H37Ra, in foot pads. Only one 
allergen per animal was injected in the neck region by the l.D. route at the induction phase with 10 
J.Lg of aflatoxins, 20 J.Lg of sterigmatocystin or 25 J.Lg of coumarin, 8-methoxypsoralen or furazolium. 
Previous treatment Challenging compound 
None Aflatoxin B1 
Aflatoxin Bt Aflatoxin B1 
None Aflatoxin B2 
Aflatoxin B2 Aflatoxin B2 
None Aflatoxin G1 
Aflatoxin G1 Aflatoxin G1 
None Aflatoxin G2 
Aflatoxin G2 Aflatoxin G2 
None Coumarin 
Coumarin Coumarin 
None Furazolium 
Furazolium Furazolium 
None 8-Methoxypsoralen 
8-Methoxypsoralen 8-Methoxypsoralen 
None Sterigmatocystin 
Sterigmatocystin Sterigmatocystin 
mJection of Freund's complete adjuvant (100 
fLg) within a few hours. Two more injections 
with the same amounts of the allergen were given 
at 48-hour intervals. After a rest period of two 
weeks, the guinea pigs were challenged. A typi-
cal delayed hypersensitivity reaction ensued in 
the immunized animals as shown in Table I. 
The rate of response was roughly inversely pro-
portional to the total amounts of the toxin used 
in immunization. In the animals sensitized with 
the lowest amount of the allergen all concentra-
tions elicited at least one positive reaction. In 
contrast, in the guinea pigs sensitized with 
laro-er amounts of the allergen, only the highest 
concentration, 1.0 fLg per site showed a signifi-
cant sensitization rate. 
The three rating systems, FR, AI and AATI in 
Table I are in good agreement with each other 
except for one value of the last AATI value in 
the fourth column. The site injected with 1.0 
fLo- in one immune animal reacted exce sively, and 
the resultant AATI value of 335 was a bit too 
high. The importance of AATI values decreases 
with a decrease in the number of positive ani-
mals, whereas AI values will remain significant 
Skin reaction read at 
24 hrs. 48 hrs. 
FR AI AATI FR AI AATI 
0/8 1.75 - 0/ 8 1.25 -
25/28 3.82 278 22/ 28 2.83 211 
0/4 1.75 - 0/4 1. 75 -
18/ 18 3.44 201 3/18 1.89 160 
3/8 2.38 180 0/ 8 0.88 -
29/29 4.69 342 19/ 29 2.89 286 
0/4 2.00 - 0/4 1.50 -
16/ 16 4.06 276 9/16 2.44 122 
1/4 2.00 151 0/4 0.25 -
10/ 10 4.90 458 8/10 3.40 247 
2/4 2.25 60 0/4 0.25 -
9/9 3.89 198 2/ 9 1.78 162 
3/4 2.50 166 0/4 1.00 -
9/ 9 5 .00 451 3/9 2.22 88 
4/4 3.00 76 0/4 1.50 -
7/ 7 4.29 366 4/7 2.72 280 
regardless of the number of positive animals be-
cause of involvement of a large number of sites or 
animals. Occasional high AA TI values in a very 
few positive controls are not significant since 
there are a few animals in a large group that 
react excessively to any stimuli; for example, 
some guinea pigs scratch the injected sites con-
taining the toxic substances with their hind 
claws. 
When these immunized animals were chal-
lenged repeatedly, the initial difference in the 
degree of sensitization due to different immuniza-
tion procedures disappeared upon the second 
challenge or thereafter and the immunological 
erythema reactions lasted longer, sometimes be-
yond 72 hours (Groups IV-VII in the second 
and seventh challenges in T able II). Skin reac-
tions with higher erythema intensities and larger 
diameters were also observed and, in addition, 
positive reactions were observed at the challenge 
doses which had initially produced relatively 
few reactions. This is very similar t o the observa-
tions reported by IVIaguire and Chase (24) with 
dinitrochlorobenzene and picric acid. In contrast, 
the toxic erythema reactions observed in con-
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TABLE IV 
Cross-reactivity of guinea pigs strongly sensitized 
to aflatoxin B1 
All chemicals were injected by I.D. route with 
2 J.l.g per site except Shalimar perfume and Berga-
mot oil which were applied topically without dilu-
tion. All animals received adjuvant at the induc-
tion phase. 
Untreated Sensitized to toxicity aflatoxin B 1 
control 
Challenging compound Fraction responded (FR ) 
read at (hrs.) 
24 48 72 24 48 72 
- - --
----
Aflatoxin B1 4/5 0/ 5 19/ 20 20/20 
Aflatoxin B2 5/6 0/6 20/ 20 15/20 
Aflatoxin G1 0/ 5 0/5 10/20 18/20 
Aflatoxin G2 5/6 0/6 20/20 12/20 
Sterigma tocystin 5/6 1/6 20/20 14/20 
Shalimar perfume 1/2 0/2 0/2 3/3 3/ 3 3/3 
Bergamot oil 1/ 2 0/2 0/2 3/3 3/ 3 3/3 
Coumarin 0/3 0/3 0/ 3 14/17 16/17 10/ 17 
8-methoxypBoralen 0/3 0/ 3 0/ 3 15/ 17 16/ 17 11/ 17 
Furacin 5/5 0/ 5 16/ 20 15/ 20 
Furazolium 4/5 0/ 5 16/ 20 15/ 20 
Benzofuran 0/3 0/3 10/ 10 9/10 
Coumarilic acid 0/ 3 0/ 3 10/ 10 9/ 10 
Umbelliferone 0/3 0/ 3 10/ 10 9/10 
Warfarin 0/3 0/ 3 10/ 10 9/ 10 
Flavone 0/3 0/3 9/ 9 9/9 
trois with or without adjuvant very rarely lasted 
beyond 4 hours (Group I in Table II). For a 
succes ful immunization neither use of adjuvant 
nor repeated immunization was required as 
shown in Table V and in Groups II and IV in 
Table II (Groups I and III are their respective 
controls). 
Other aflatoxins B2, G1 and G2 (Fig. 1, 2-4) 
have chemical structures very similar to aflatoxin 
B1 and they were as allergenic as aflatoxin B1 
(Table III). In most cases, aflatoxins G1 and G2 
showed tronger allergenicity than aflatoxins B1 
and B2. The mycotoxin sterigmatocystin (Fig. 
1, 5), coumarin (Fig. 2, 1), furazolium, a nitro-
furan (Fig. 3, 4) and 8-methoxypsoralen, a furo-
coumarin (Fig. 2, 5) were also allergenic under 
similar experimental conditions (Table III). 
Coumarin and 8-methoxypsoralen were strongly 
allergenic by showing stronger erythema inten-
sity and wider erythema area with resultant in-
crease in AI and AA TI values (Table III) . 
The guinea pigs that had been strongly sensi-
tized by repeated challenges with aflatoxin B1 
(Tables I and II) were challenged with the other 
afiatoxins B2, G1 and G2, sterigmatocystin and 
aflatoxin B analog I (5, 7-dimethoxy cyclopen-
tenonecoumarin) (Fig. 2, 2). All showed positive 
reactions, indicating an immunological cross-
reactivity to these structurally closely related 
compounds. They also reacted to the topical 
challenges of Bergamot oil (essential oil) and 
Shalimar perfume, implying that aflatoxin B1 
was immunologically cross-reacting to isomers 
of furocoumarins (psoralens and angelicins) 
(Fig. 2, 5 and Fig. 2, 6 respectively), as shown in 
TABLE V 
Cross-reactivity of guinea pigs weakly sensitized to 
aflatoxin B 1 
The animals were immunized with 9 topical 
applications of 80 p,g total aflatoxin B 1 in acetone 
and/ or two I.D. injections of total 35 p,g in the 
absence of adjuvant at the induction phase and 
challenged with 4 p,g of mycotoxins. The challeng-
ing dose for aflatoxin B analog I was 2 p,g per site. 
All animals were chall enged by I.D. route . 
Skin erythema 
reaction at 24 
Immuniza tion Challenging hrs. 
route mycotoxin 
1-< 
P:: 1-< 
E-< 
<: 
~ <: <: 
-- - - -
None Aflatoxin B1 0/ 5 0.40 -
I.D . Aflatoxin B1 3/6 2.00 54 
Topical plus I.D. Aflatoxin B1 0/ 11 1.18 -
None Aflatoxin B 2 0/6 1.33 -
I.D. Aflatoxin B2 2/6 2.17 472 
Topical plus I .D. Aflatoxin B 2 4/11 2.27 183 
None Aflatoxin G1 0/ 5 0.00 -
I.D. Aflatoxin G1 0/6 0.00 -
Topical plus I .D. Aflatoxin G1 0/ 11 0.00 -
None Aflatoxin G2 0/ 5 1.20 -
I.D . Aflatoxin G2 2/6 2.17 169 
Topical pi us I.D. Aflatoxin G2 6/11 2.55 120 
None Aflatoxin B ana- 2/6 2.16 169 
log I 
I.D . Aflatoxin B ana- 5/6 3.50 292 
log I 
Topical plus I.D. Aflatoxin B ana- 8/11 2.65 207 
log I 
None Sterigma to- 3/6 1.67 33 
cystin 
l.D. Sterigma to- 1/6 1.83 192 
cystin 
Topical plus I.D. Sterigma t o- 2/11 2.00 207 
cyst in 
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4. 
5. 
6. 
COUMARIN 
AFLATOXIN B ANALOG I 
WARFARIN 
8-METHOXYPSORALEN 
5-METHOXYANGEUCIN 
( ISOBERGAPTENE ) 
FIG. 2. Coumarins and furocoumarins 
Table IV. These animals or animals newly sensi-
tized to aflatoxin B1 showed varying degrees of 
cross-reactivity in response to the I.D. challenges 
of coumarin, 8-methoxypsoralen, umbelliferone 
(Fig. 2, 3), warfarin (Fig. 2, 4), benzofuran (Fig. 
3, 1), coumarilic acid (Fig. 3, 2), furacin (nitro-
furazone) (Fig. 3, 3), furazolium chloride (Fig. 
3, 4) and flavone (2-phenyl-y-benzopyrone). 
These strongly sensitized animals lost immuno-
logical specificity and became reactive to many 
compounds chemically related to the original 
allergen (Table III). 
However, the guinea pigs that were lightly 
sensitized to aflatoxin B1 by repeated topical 
application and/or I.D. injections without ad-
juvant showed no reactivity to aflatoxin G1 or a 
very negligible reactivity to sterigmatocystin 
with I.D. challenge dose of 4 p,g per site (Table 
V). These animals were moderately reactive to 
aflatoxin B2, Gz and aflatoxin B analog I (Table 
V). These results may be interpreted as more 
immunological specificities for the intact rigid 
dihydrofurofurocoumarin or the dihydrofuro-
furochromone than the flexible tetrahydrofuro-
furans. Although it is difficult to understand the 
immuno-specificities of delayed hypersensitivity, 
the above results point out two factors involved. 
One is the degree of immune state of the host 
and the other the challenging dose, since these 
guinea pigs had been reactive to aflatoxin B1 with 
challenge doses of 15-20 Jl-g but unreactive with a 
4 Jl-g dose of I.D. challenge. 
No evidence for the presence of circulating 
antibodies could be found with our methods. 
Injection of sera collected from strongly im-
munized guinea pigs into untreated guinea pigs 
by intradermal and peritoneal routes and chal-
lenging them with the allergen did not show any 
stronger skin reactions than the controls that 
received sera from untreated animals. 
DISCUSSION 
Aflatoxin B1 is highly cytotoxic (1, 26-28), 
inhibits biosynthesis of proteins and nucleic 
acids (8-16), and is known to be an immuno-
suppressant for formation of antibodies against 
bacterial antigens (29). These properties of 
aflatoxin B1 and other highly toxic mycotoxins 
may lead to failure in induction of delayed 
hypersensitivity at high concentrations. Cou-
marin, 8-methoxypsoralen and furazolium 
showed a higher sensitization rate at a lower 
concentration (10 }J-g per animal) than at a 
higher concentration (25 }J-g per animal). All 
of these compounds possess varying degrees of 
1. BENZOFURAN cD 
2. COUMARILIC ACID 
HOOCi:D 
3 . FURACIN (NITROFURAZONE) 
D 0 N 0 CH=N-N-~ -NH 
2 H 6 2 
4. FURAZOLIUM 
CHLORIDE [ sy l O,N~- J CI-
FIG. 3. Furans 
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antiseptic activities and they are probably 
cytotoxic to those cells which participate in im-
munogenesis of both humoral and cellular types. 
For a succe sful sensitization without the elabo-
rate experimental schemes to determine the opti-
mal amount, it may be advantageous to try an 
I.D. injection of a few micrograms with the 
usual rest period, 10-15 days, or a larger amount 
(20--30 JLg) with longer rest periods (3-4 weeks). 
Cases of delayed hypersensitivity by 8-methoxy-
psoralen (23) and furans (30, 31) have been re-
ported only in man. Many of these important 
anti eptic and other medicinal compounds can 
be ·creened or studied in animals before trials on 
man for pos ible sen itization capabilities. 
The detection of delayed hypersensitivity to 
toxic allergens is a rather difficult matter. For a 
weak immune state a larger dose (10--20 JLg 
aflatoxin B1 per ite) seems advantageou for 
I.D. challenges. At higher doses the erythema 
reaction due to toxicity was too strong and, in 
addition, the complex biological immune re-
sponse for a positive skin reaction may be 
suppres ed. Our present knowledge of the effects 
of these mycotoxins or other toxins on individual 
cell populations (lymphocytes, macrophages, 
neutrophils, etc.) which participate in these im-
mune reactions is very limited. When the toxicity 
is too high, the reading of the skin reactions 
should be continued for several days. The 
erythema cau ed by primary irritation or toxic-
ity sub ides earlier than that due to delayed 
hypersen itivity. For untried allergens it may be 
wise to te t four concentrations in duplicate 
whose ucces"ive dilutions differ by a factor of 5 
or 10. An eliciting dose of an allergen seems to 
require a threshold value; this amount is not a 
fixed quantity but varies in inverse proportions 
to the intensity or degree of immune state of 
the host. For example, the highly immunized 
guinea pigs in Table II showed strongly positive 
reactions upon challenge with 0.1 or 0.2 }Lg of 
aflatoxin B1. The poorly immunized animals in 
Table V did not respond to the challenge with 4 
}-tg, whereas these same animals responded well 
to previous and later challenges with 15 or 20 
}kg of aflatoxin B1. 
The immunological specificity of delayed hy-
persensitivity or cellular immunity may depend 
on many factors such as the degree of the im-
mune state of hosts, challenging doses, penetra-
tion rate when applied topically and the stabil-
ity, especially the metabolic stability, of the 
allergens. If some of the barriers are removed as 
in burn patients, the hosts may become reactive 
to many substances. Cross-reactivity was more 
extensive when the hosts were challenged by the 
intradermal route than the topical route with 
many allergens. Mitchell and Shibata (32) 
observed immunological stereoisomeric specificity 
of dibenzofurans and chromones, and cross-
reactivity among the depsides by patch tests on 
forest workers who were sensitive to lichenized 
fungi. It may be interesting to see whether the 
I.D. test may give different or similar results 
with these patients. The original sensitizers used 
to immunize the animals were not always the 
strongest reactors and often cross-reacting sub-
stances gave stronger reactions at an equal 
weight or equimolar basis. Although these myco-
toxins and their component chemicals exhibited 
strong cross-reactivity in moderately or strongly 
immunized animals, the immunological responses 
of the lightly sensitized guinea pigs differed de-
pending on the structural or conformational dif-
ference between the cross-reacting substances and 
the original allergen, in our recent preliminary 
investigation . Humans often come into contact 
with the e chemicals as medicine, food, cosmetic 
or in natural environment ; therefore, further 
careful studies should be made. 
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